Microbiota Medicine – Major Advances and Clinical Translation

The human microbiome plays a crucial role in health and disease, opening new frontiers in precision medicine. This session will explore the latest breakthroughs in microbiota-based therapies and their translation into clinical practice.

Experts will discuss the evolving landscape of microbiome-targeted interventions, from innovative treatments to regulatory and implementation challenges.

Key topics include:

• Translating microbiome research into clinical practice – How cutting-edge discoveries are shaping patient care.
• Phage therapy – Emerging applications, efficacy, and challenges in combating bacterial infections.
• Probiotics, prebiotics, and postbiotics – Advances in microbiome-based interventions for gut and systemic health.
• Fecal microbiota transplantation (FMT) – The latest evidence on its safety, efficacy, and regulatory landscape.
• Next-generation microbiome therapeutics – Drug development strategies harnessing microbiome science.
• Clinical trials and case studies – Real-world insights into microbiota-targeted therapies.

 

For more information, please click here.